Webinar on

Vaccines & Vaccination

Vaccine 2020

Theme: Advances in Immunology & Vaccine Technology And Their Impact

Webinar on Vaccines & Vaccination is delighted to welcome the participants from all over the world to be a part of the summit. Vaccine 2020 is scheduled on December 14-15, 2020 in Duabi, UAE. This webinar will be organized around the theme “Advances in Immunology & Vaccine Technology And Their Impact”. Vaccine 2020 will be a platform for plenary speakers, Keynote speakers, Invited speakers and Young Researchers as well as for the youth generation. The summit will work as a discussion point for researchers and experts from all around the world to discuss the cause, effect, prevention as well as the future roadmap of a Vaccine & Vaccination.

 

Meetings International is announcing Young Scientist Awards through 3rd International Conference on Vaccines & Vaccination (Vaccine 2020) which is scheduled at Osaka, Japan during May 26-27, 2020. This Vaccine Conference focuses on “Advances in Immunology & Vaccine Technology and their Impact”.

Vaccine 2020 and upcoming conferences will recognise participants who have significantly added value to the scientific community of environmental science and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Vaccine 2020 focuses mainly on Immunology, Vaccine Technology, Nano Vaccine Technology, Antibiotics, Plant Vaccines, Cancer vaccines. Vaccine Conference Operating Committee is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.

Eligibility:

Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. candidates. Persons from Scientific Industry can also participate.

Benefits: The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.

  • Acknowledgement as YRF Awardee
  • Promotion on the conference website, Young Researcher Awards and certificates
  • Link on the conference website
  • Recognition on Meetings Int. Award Page
  • Chances to coordinate with partners around the world
  • Research work can be published in the relevant journal without any publication fee

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue
  • All the awards will be selected by the judges of the award category
  • The winners of the Young Scientist Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference
  • Each individual participant is allowed to submit maximum 2 papers
  • Abstract must be submitted online as per the given abstract template
  • Abstracts must be written in Times New Roman and font size will be 12
  • Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference

Conditions of Acceptance:

To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT, and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:

Official announcement of the recipients will occur after the completion of Vaccine Conference.

Session On: Cancer Vaccine

A vaccine stimulates the immune system to produce antibodies to fight a disease. Global Cancer Vaccines Market is expected to reach at $12,814 million from $4,073 million and register a CAGR of 17.7%, during the forecast period, 2017 - 2023. The global cancer vaccines market is driven by increase in the prevalence of human papilloma virus (HPV) infections, administration of prophylactic cancer vaccines, high investments & government funding in the development of cancer vaccines, and launch of new cancer vaccines. The pediatric cancer vaccines segment possesses high market potential for growth in the market, owing to increase in traction of prophylactic vaccines among children. However, the adult cancer vaccines segment dominated the global market owing to increase in incidence of human papilloma virus infections in adults, for the forecast period. Furthermore, rise in cancer incidence in India cause approximately 6, 00,0007, 00,000 deaths, thus, growing the need for prophylactic and therapeutic cancer vaccines.

Vaccine Conferences| Vaccination Meeting| Vaccine Congress| Conference on Vaccine| Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences | Vaccines Conferences-2020| Immunization Conferences-2020| HIV Vaccines Conferences | Vaccines Relative Conferences

Session On: Emerging Disease:

Infectious diseases are the leading cause of morbidity and mortality across the globe. Diagnostics is the first step for the treatment and eradication of infectious diseases. Owing to ever-evolving pathogens and emerging new diseases, there is an urgent need to identify suitable diagnostics technique for better treatment of each disease. Moreover, effective diagnostic techniques are important for the identification of the diseases and better treatments as well as control of outbreak in the population.Geographically, the global infectious diseases diagnostics market is segmented into North America, Europe, Asia-Pacific, Central & South America, and Middle East and Africa. North America held the largest share of the market in 2018. According to the World health Organization estimates, infectious diseases are responsible for more than half of child mortality in Asia-Pacific region. Furthermore, innovative technologies and growing research and development activities by major key players further propelling the market growth in the region.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences | Vaccines Conferences-2020| Immunization Conferences-2020| HIV Vaccines Conferences | Vaccines Relative Conferences

Session On: Diabetes Vaccine

Type 1 diabetes is an autoimmune disease which, when triggered, causes the body’s own ‘killer’ T cells to kill off the pancreas’s insulin producing beta cells. Diabetes vaccines attempt to stop the T cells from attacking the body's own cell. It’s possible to block the effects of the immune system by using immunosuppressants, but this would make people more vulnerable to infections. An ideal type 1 diabetes treatment would block the immune cells attacking the pancreas while leaving the rest of the immune system untouched. New research suggests that this could be possible. The researchers highlight that antibodies to GAD, IA2 or insulin are present in 95% of pre-diabetic or new-onset type 1 diabetes patients. In fact, 80% of patients are positive for two or more of these antibodies, and 25% are positive for all three antibodies.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences | Vaccines Conferences-2020| Immunization Conferences-2020| HIV Vaccines Conferences | Vaccines Relative Conferences

Session On: Poultry Vaccine

The global poultry vaccines market is accounted for USD 13,35.81 million in 2017 and expected to register ~7.25% CAGR during the forecast period (2018–2023). The European poultry vaccines market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The poultry vaccines market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The poultry vaccines market in the Middle East & Africa has been segmented into the Middle East and Africa.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences | Vaccines Conferences-2020| Immunization Conferences-2020| HIV Vaccines Conferences | Vaccines Relative Conferences

Session On: Malaria Vaccine:

Malaria remains one of the world’s leading killers, claiming the life of one child every two minutes. Most of these deaths are in Africa, where more than 250 000 children die from the disease every year. Children under 5 are at greatest risk of its life-threatening complications. Worldwide, malaria kills 435 000 people a year, most of them children. Thirty years in the making, RTS, S is the first, and to date the only, vaccine that has demonstrated it can significantly reduce malaria in children. In clinical trials, the vaccine was found to prevent approximately 4 in 10 malaria cases, including 3 in 10 cases of life-threatening severe malaria.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences | Vaccines Conferences-2020| Immunization Conferences-2020| HIV Vaccines Conferences | Vaccines Relative Conferences

Session On: Vaccines Research & Development

Vaccine Development is a process that mainly focuses on a different variety of technological initiatives and applied research, which enhance and promote new systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak world wide research and industry response and as we continue to search for solutions, we must review the lessons gained in order to overcome the current problems. Vaccines development is a long, complex process, often lasting 10-20 years and involving a combination of public and private participation. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences

Session On: Plant Vaccines

Plant-based immunization advancements include the involement of the coveted qualities encoding the antigen protein for particular illness into the genome of plant tissues by various strategies. Agrobacterium-interceded quality exchange and change by means of hereditarily altered plant infection are the normal techniques that have been utilized to make viable antibodies. Indeed, even with every one of the impediments, nonstop endeavors are as yet progressing so as to create effective immunization for some human beings and creature’s related diseases attributable to its awesome possibilities.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences

Session On: Pregnancy & Neonatal Vaccines

Vaccination given for children are called children Immunization. It is recently recommended that all children receive vaccination against the infectious diseases unless the children has some special circumstances, such as a compromised immune system or neurological disorders. In our mobile society, over a billion people each day people travel to and fro from other countries, where many vaccine-preventable diseases remain relativelyvery common. Without vaccines, epidemics of many preventable diseases could not be cured, resulting in increased - and unnecessary - illness, disability, and death among children.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences

Session On: Veterinary Vaccines

Veterinary vaccines are to improve the health and welfare of animals and also  protect its health along public health, reducing animal suffering, enabling efficient production of food animals to feed the burgeoning human population, and greatly reducing the need for antibiotics to treat food and companion animals. Prominent examples include rabies vaccines and rinderpest vaccines. Recently for rabies a third generation rabies vaccine has been developed using recombinant technology for domestic animals and wildlife. Depending upon the expression system these vaccines are used either parenterally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences

Session On: Vaccine Regulation and its Safety & Efficacy

Vaccines are some of the safest medical products available, but like any other medical product, there may be health risk. Accurate information about the value of vaccines as well as their possible side-effects helps people to make informed decisions about vaccination.  Vaccine efficacy is the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an  effective vaccine.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences

Session On: Nano Vaccine Technology

In spite of the advancement of traditional antibodies, enhancements are plainly required because of worries about the powerless immunogenicity of these Vaccines, natural insecurity in vivo, toxicity, and the requirement for different organizations. To defeat such issues, nanotechnology stages have as of late been fused into Vaccine development. Nano carrier-based delivery system offers a chance to improve the humoral and cell Immune response.

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences

Session On: Alzheimer Vaccine

Alzheimer's illness, the most widely recognized type of dementia, is a degenerative neurological ailment. About 5.7 million Americans have Alzheimer's illness, as per the University of Texas. The number could twofold by 2050. Memory issues are frequently the principal indication of the condition, which consistently advances after some time. Prior examinations exhibited that acquainting antibodies with amyloid proteins altogether diminishes protein development. In the mid 2000 s, researchers utilized this learning to make an antibody. In any case, when they tried the immunization in people, it caused aggravation in the minds of 6 percent of the members, making it too perilous to be in any way usable

Vaccine Conferences | Vaccination Meeting | Vaccine Congress | Conference on Vaccine | Vaccine Therapy | Vaccine Research | Vaccinology Congress | Vaccination Conference| Vaccines Conferences| World Vaccine Congress| Immunology Conferences

Why Japan?

Osaka was evaluated in Research & Development only. Osaka currently markets vaccines in Japan only and is growing its vaccine pipeline, including R&D projects for dengue and chikungunya. Osaka performs above average in Research & Development, and has clear access provisions for its late-stage vaccine candidate. While it does not currently market vaccines in countries in scope, it is taking steps to support affordability and supply of vaccines in its pipeline. For example, from 2016, Osaka has been developing a low-cost IPV with support from the Bill & Melinda Gates Foundation. The beginning stages of early traditions of visits to lovely destinations. Japan's rich history can be experienced most wherever in the country. With numerous old royal residences so far remaining the nation over, it's definitely not hard to set aside a trip back in chance to a place that is known for medieval rulers. The Travel and Tourism Competitiveness Report 2017 positions Japan fourth out of 141 countries for the most part, which was the best in Asia. Japan got for the most part high scores in all viewpoints, especially human services and cleanliness, wellbeing and security, social resources and business travel.

Vaccine & Vaccination  Market Research

Importance and scope

Vaccination is one of the most successful achievements in medicine. Vaccine Immunology upgrades our comprehension of the resistant reaction in wellbeing and illness by exhibiting critical clinically applicable research, including new creature models for human immunologic infections. Vaccination itself cannot cause formation of disease against which it is intended. Vaccines have historically been the most effective means to fight and eradicate infectious diseases. Vaccinations of animals are used both to prevent their contracting diseases and to prevent transmission of disease to humans. Vaccination given during childhood is generally safe. Effectiveness of vaccination is unambiguously proven by regression up-to clearance of many diseases preventable by vaccination. Limitations to their effectiveness, nevertheless, exist. Influence of vaccination can be best illustrated on eradication of smallpox in the world one of the most contagious and deadly diseases in humans.

Global Vaccine Market

 The vaccines market is expected to reach USD 49.27 Billion by 2022 from USD 34.30 Billion in 2017, at a CAGR of 7.5%. The growth of the market is attributed to the rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing investments by companies.

Newer and more expensive vaccines are coming into the market faster than ever before. Vaccine development: increasing investment. Tripled in value from USD 5B in 2000 to almost USD 24 B in 2013 – Influenza vaccine market: estimated at $2.9 billion in 2011 to $3.8 billion by 2018 – US : $1.6 billion in 2011 to $2.2 billion in 2018. Global market projected to rise to USD 100 B by 2025 .More than 120 new products in the development pipeline. Changing status of the vaccines within the pharmaceutical industry . New business model for vaccines is emerging.

Global Statistics of Vaccines

Global Influenza Vaccine Market – Will Increase to US$ 5.74 Billion by the Year 2022 – Research and Markets.

The study based on Evaluate Pharma survey shows that at the end of 2013 the sales volume of global vaccine market was $ 25.6 billion and is expected to rise to $41.3 billion by 2020.

Global antibacterial vaccination market

Global Antibacterial Drugs Market to 2022: Antibacterial Drug Market will Hit $35.6 Billion by 2022, as Efforts Increase to Tackle Antimicrobial Resistance - Research and Markets.

Global antibacterial vaccination market is expected to experience healthy growth across the forecast period due to rising profits for several classes of drugs. Vaccines will still be the leading revenue-generating drugs in the market in 2022, despite the influx of new protein synthesis inhibitors and the release of several new cell-wall synthesis inhibitors.

Conjugate vaccines to dominate the market in 2017-2018

Predicated on technology, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, and toxoid vaccines. In 2018, the conjugate segment is expected to account for the most immensely colossal quota of the vaccines market. The magnification in this market is mainly driven by incrementing investments by the regime of developing countries and elevating prevalence of infectious diseases.

Predicated on disease denotement, the pneumococcal segment is projected to grow at the highest CAGR during the forecast period.

By disease designation, the vaccines market is segmented into pneumococcal disease, influenza, DTP, hepatitis, human papillomavirus (HPV), rotavirus, meningococcal disease, MMR (measles, mumps, and rubella), varicella, polio, dengue, and other disease designations. The pneumococcal segment is expected to register the highest rate during the forecast period. The magnification in this segment can primarily be attributed to the incrementing regime investments in pneumococcal vaccination programs and high prevalence of pneumococcal disease.

Market outlook of the global human vaccine market

Technavio’s market research analyst presages the ecumenical human vaccine market to grow rapidly at a CAGR of more than 11% by 2020. This market’s steady magnification rate is heavily influenced by the inclusion of several pediatric vaccines in the national immunization schedule of sundry countries. This avails in incrementing the consumption of vaccines, which in turn fosters market magnification during the prognosticated period.

America Region

The global vaccines market is segmented based on technology, type, disease indication, end-users, and regions. The conjugate vaccines segment is expected to register the highest growth rate in the vaccines market, by technology, during the forecast period. The high growth in this segment is attributed to the increasing company investments in development of new vaccines.

The vaccines market is expected to reach $48.03 billion by 2021 from USD 32.24 billion in 2016 at a CAGR of 8.3% driven by increasing focus on immunization programs and rising government and nongovernment funding for vaccine development while North America is expected to dominate the market globally.

Europe Region

The Vaccines Europe surveys, provide an insight into the innovation, research and development, employment and manufacturing undertaken by the industry in Europe. With the information collected every two years, Vaccines Europe’s database reveals industrial trends that can assist policy makers and other stakeholders concerned with Europe’s social and economic development.

Europe Influenza Vaccine Market was close to US$ 1Billion. In children vaccine market, United Kingdom is ahead and France holds the second spot. In adult vaccine market United Kingdom and Germany have are on equilibrium.

Asia pacific Region

The Asia-Pacific Cancer Vaccines Market was worth $ 0.46 billion in 2016 and estimated to reach $ 1.05 billion by the end of 2021 with a growing potential of 18.24 %.  The Asia-Pacific DNA vaccine market was estimated to be worth $154 million in 2016. The market is predicted to grow at the highest CAGR of 45.85% over the forecast period of 2017-2025, generating $4874 million by its end.

Middle East Region

The Middle East and Africa offer immense potential and opportunities for the vaccine market. Apart from the unmet needs for vaccination, second most important market driving factor are the policies of national Governments and international bodies such as World health organization (WHO).

The market’s trends include strong research pipeline under which number of novel vaccines are being developed such as rubella vaccine, ebola vaccine etc. DNA recombinant technology is also a common technology used in the development of novel acting vaccines.

Associations & Societies Associated with Vaccines in and around Osaka:

  • Japanese Society for Immunology(JSI)
  • The Japanese Society for Vaccinology
  • The Japanese Society of Virology
  • The Japanese Association Of Medical Sciences
  • Japan Society of Immunology and Reproduction
  • Japan Pediatric Society

Global Associations & Societies Associated with Vaccines:

  • European Federation of Immunological Societies, Itlay
  • The International Society for Interferon and Cytokine Research, USA
  • The International Society of Neuroimmunology, Itlay
  • British Society for Immunology, UK
  • Infectious Diseases Society of America, USA
  • The Society for Mucosal Immunology, UK
  • The Society for Leukocyte Biology, Germany
  • Immune Deficiency Foundation., USA
  • The International Union of Immunological Societies, Germany
  • European Society of Gene Therapy, Germany
  • Federation of African Immunological Societies, Tunisia
  • Federation of Clinical Immunology Societies, USA

Universities associated with Vaccines globally:

  • Osaka University, Japan
  • Angeles University Foundation, Philippines
  • Moscow State Medical University, Russia
  • Shanghai Medical University, China
  • Qingdao University, China
  • University of Jordan, Jordan
  • Kasr El-Aini Faculty of Medicine, Cairo University, Egypt
  • Arak University of Medical Sciences, Iran
  • Oman Medical College, Oman
  • Riyadh.College of medicine, Saudi Arabia
  • University of Minho, Portugal
  • Medical University of Lublin, Poland
  • Saba University School of Medicine, Netherlands
  • University of Western Brittany, France
  • University of Southern Denmark, Denmark
  • Harvard University, USA
  • University of California--San Francisco, USA
  • Stanford University, USA
  • Yale University, USA
  • Johns Hopkins University, USA

Industries associated with Vaccines in worldwide:

  • GlaxoSmithKline plc (U.K.)
  • Pfizer, Inc. (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Sanofi Pasteur SA (France)
  • CSL Limited (Australia)
  • Emergent BioSolutions, Inc. (U.S.)
  • Johnson & Johnson (U.S.)
  • MedImmune, LLC (U.S.)
  • Daiichi Sankyo Company, Limited (Japan).
  • Mitsubishi Tanabe Pharma Corporation (Japan)
  • Astellas Pharma Inc. (Japan)
  • Serum Institute of India (India)
  • Bavarian Nordic (Denmark)

Conclusion

Vaccines are necessary — and good hygiene, sanitation, clean water, and nutrition are insufficient for stopping infectious diseases. If we don’t maintain optimum rates of immunization or “herd immunity”, the diseases prevented by vaccination will return. While better hygiene, sanitation and clean water help protect people from infectious diseases, many infections can spread regardless of how clean we are. If people are not vaccinated, diseases that have become uncommon such as pertussis (whooping cough), polio and measles, will quickly reappear.

References

https://www.marketsandmarkets.com/PressReleases/vaccine-technologies.asp

http://www.who.int/immunization/programmes_systems/procurement/market/en/

https://www.technavio.com/report/global-vaccines-human-market

https://www.aboutpharma.com/blog/2017/05/02/global-influenza-vaccine-market-will-increase-to-us-5-74-billion-by-the-year-2022-research-and-markets/

Meetings International has always been at the forefront to support and encourage the scientific and techno researchers to march forward with their research work. 3rd International Conference on Vaccines & Vaccination offers various awards as reorganization to exceptional researcher and their research work. We invite all enthusiastic researchers from all around the world join us for the Vaccine Conference scheduled in Osaka, Japan on May 20-21, 2020.

Eminent Key Note Speaker Award:

Vaccine 2020 Conference will confer the Model Key Note Speaker Award to the researchers who have spent a considerable time of their academic life towards the research related to conference topic. Key note speaker award is for the researchers/speakers who have done all the hard work behind the scene. It will be a small clap for their dedication and hard work.

Outstanding Speaker Award:

Vaccine 2020 Conference will bestow model speaker award to those researchers who have made significant contribution towards the conference topic during their research period as well as presented the research topic in an impressive way in the oral presentation during the summit. It will be an apt appreciation from the Jury as well as from the delegates. The award they receive will motivate them to march forward with the research work.

Model Organizing Committee Member Award:

Vaccine 2020 Conference will take this opportunity to facilitate eminent experts from this field with the model Organizing Committee Member award for their phenomenal contribution towards the society through their academic research.  This will be a trivial but significant reorganization of their dedication and discipline.

Promising Young Researcher Award:

The motive of this Award during the Vaccine 2020 Conference is to appreciate research work of the budding young researcher who is continuing their research work to create a better society. The award will provide them a tremendous amount of encouragement to keep moving forward.

Educative Poster Award:

The educative poster award for the Vaccine 2020 Conference will be endorsement for those who wishes to display their research paper through a poster and will act as a guiding force those researchers. The award will be presented to the most informative and educative research poster.

Criteria:

  • All presented abstracts will automatically be considered for the Award.
  • All the presentation will be evaluated in the conference venue.
  • All the awards will be selected by the judges of the award category.
  • The winners will be formally announced during the closing ceremony.
  • The winners of the Poster Award will receive award certificate.
  • The awards will be assessed as far as plan and format, intelligence, argumentation and  approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

  • All submissions must be in English.
  • The topic must fit into scientific sessions of the conference.
  • Each individual participant is allowed to submit maximum 2 papers.
  • Abstract must be submitted online as per the given abstract template.
  • Abstracts must be written in Times New Roman and font size will be 12.
  • Abstract must contain title, name, affiliation, country, speaker’s biography, recent photograph, image and reference.
  • Each poster should be approximately 1x1 M long. The title, contents and the author’s information should be clearly visible from a distance of 1-2 feet.

3rd International Conference on Vaccines & Vaccination brings upon an incipient platform to share and discuss all the innovations and potential benefits and limitations of vaccines in preventing and control of diseases. Vaccine 2020 is organizing an outstanding Scientific Exhibition/Program and anticipates the world’s leading specialists involved in. Vaccine 2020 organizing committee anticipates over 300 participants to attend this premier event. Your organization will benefit with excellent exposure to the leaders in Vaccines and Clinical Trails. Vaccine 2020 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your industry may offer to a broad international audience.

Meetings International  runs strategic International Conferences, Business Meetings, Workshops, Symposiums across the Healthcare, Life Science, Pharma, Medicine, Agri, Food, Clinical, Medical, Applied Sciences, Applied Engineering and Business Management segment all-round the globe throughout the year. We at Meetings International work parallelly with you to understand your business needs, marketing strategies & goals to reach out new customers and penetrate your brand in new markets. The team Meetings Int., work together to help you in exploring new customer base, reach to your target audience and help you in meeting the influencing personality and decision makers as well. Meetings Int. provides a unique platform where industry meets academia, and business stakeholders meet the customer pool. Our networking sessions will help you to interact with all the stakeholders in the respective segments.

Grow your business globally and sell your research materials, pharmaceuticals, Antibodies, Clinical Reagents, Chemicals, instruments, or you are looking to recruit that next investigator. Meetings International is providing opportunity to advertise and connect with the experts and leaders across the world.

Advertisement banner must be provided by the advertising company and must be in the jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.

For further queries, connect our conference manager at vaccine@annualmeetings.net; sponsor@meetingsint.com

You can also connect us via WhatsApp: +65 3158 1626 / + 44 7482 874377

Google Analytics Metrics of Vaccine 2020:

  • The visitor’s traffic is the benchmark for the success of conference and Vaccine 2020 is constantly attracting viewers across the world.
  • According to the Google Analytics, more than 14,780+ monthly audiences are visiting to our conference websites for submitting abstracts, brochure downloads, registration, exhibition and sponsorship queries.
  • Readers from the major countries including United States, Japan, United Kingdom, European Union, Asia-Pacific and Middle East visit our conference domain to participate and present their latest research.

Google Analytics Metrics of Meetings International:

  • 437,380 + Users
  • 1,606,987 + Page views
  • 644,430 Sessions at the rate of 1.47 per user

Meetings International has so far received 644,430 Sessions which confirm the outstanding pool of new users and visitors. Meetings International works on Open Access publishing model, hence they are the best choice for the scholars and authors worldwide. We understand the importance of timely communication and our efficient and quick review process avoids unnecessary delays in the production, publication and circulation of the published material worldwide with in no time while enhancing the visibility of the authors and conferring credibility to scholars and readers.

The promotion of the individual author contributions is taken care of and hence the authors enjoy the reputation among global audience. Meetings International  values the contributions by the authors and takes adequate measures in propagating and promoting their outcomes by permanently archiving as well.

 

 

  • Alzheimer Vaccine
  • Cancer Vaccine
  • Emerging Disease
  • Diabetes Vaccine
  • Poultry Vaccine
  • Malaria Vaccine
  • Vaccines Research & Development
  • Plant Vaccines
  • Pregnancy & Neonatal Vaccines
  • Veterinary Vaccines
  • Vaccine Regulation and its Safety & Efficacy
  • Nano Vaccine Technology

5 Organizing Committee Members

OCM Member
Martin D Souza

Professor
Mercer University
USA

OCM Member
Giulio Tarro

President
Foundation T. & L. de Beaumont Bonelli
Italy

OCM Member
Ahmed Hegazi

Professor
National Research Center
Egypt

OCM Member
Mostafa Norizadeh Tazehkand

Professor
Bulent Ecevit University
Turkey

OCM Member
Orkideh Hajipour

Professor
Pamukkale University
Turkey

More...

Media Partners & Collaborations

Vaccine 2020

Media Partner

Vaccine 2020

Media Partner

Vaccine 2020

Media Partner